EX-10.2
Viking Therapeutics, Inc.
CONSULTING AGREEMENT
This Consulting Agreement (the “Agreement”) is entered into on July 28, 2026 and effective as of August 1, 2026 (the “Effective Date”) by and between Marianne Mancini, an individual (“Consultant”), and Viking Therapeutics, Inc., a Delaware corporation (together with its successors and assigns, “VIKING”), having a principal place of business at 9920 Pacific Heights Blvd, Suite 500, San Diego, CA 92121. Consultant or VIKING may be referred to herein as a “Party” and collectively as the “Parties.”
RECITALS
WHEREAS, VIKING wishes to engage Consultant to provide the services described on Exhibit Ahereto (collectively, “Consulting Services”) and Consultant is willing to provide these services to VIKING during the Term (as defined below); and
NOW, THEREFORE, in consideration of the mutual premises and the mutual covenants set forth herein, the Parties, intending to be legally bound, hereby agree as follows:
1.
…